Oct 21, 2020
Financing to accelerate first mover advantage of Protein Printing™ technology which enables revolutionary efficiencies in protein manufacturing. VANCOUVER, Wash., Oct. 20, 2020 /PRNewswire/ -AbSci, a growth-stage synthetic biology company whose Protein Printing™...
Oct 20, 2020
Months after nailing down a $10.4 million Series D and a partnership with French pharma giant Sanofi, AbSci is pulling in its largest fundraise yet — $65 million to advance what it calls its protein printing tech. The Vancouver, WA-based biotech is working on a more...
